Interventional agents safety and pharmacokinetics services
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N93025D00014
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Last date to order 15% complete
- IDV ceiling
- $50,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 17 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a single-award indefinite-delivery contract to Sri International on September 15, 2025, with a ceiling value of $50 million and an ultimate completion date of September 14, 2032.
The contract covers interventional agents safety and pharmacokinetics services, supporting drug candidate development and toxicology evaluation. Place of performance is not specified in the source. The period of performance runs from September 15, 2025 through September 14, 2032.
Sri International is a non-profit research and development organization headquartered in Menlo Park, California. The contract is one of two single-award indefinite-delivery vehicles NIAID holds with Sri International for interventional agent services; the companion vehicle covers Interventional Agents Chemistry Services at the same ceiling and performance period.
Recent ordering activity under NIAID's master IDIQs with Sri International for nonclinical safety testing, animal model development, and interventional agent chemistry services shows individual task orders valued from approximately $830 thousand to $16.2 million. Charles River Laboratories frequently serves as a subcontractor on Sri's biomedical research awards for laboratory animal procurement and preclinical services.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93025D00014?
75N93025D00014 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2025.
How much is contract 75N93025D00014 worth?
75N93025D00014's own ceiling is $50,000,000.
Who can order from contract 75N93025D00014?
75N93025D00014 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N93025D00014 competed?
The extent of competition for 75N93025D00014 was full and open competition. The government received 17 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV